Last reviewed · How we verify

NCT05909865: PRIME

PRedIcting MEniscal Tears Outcomes After Physical Therapy Treatment

Suspended NA Last updated 25 May 2025
What this trial tests

NA trial testing Therapeutic resistance exercise in Meniscus Tear in 386 participants. Suspended.

Timeline
1 May 2024
Primary endpoint
20 May 2025
20 May 2025

Quick facts

Lead sponsorHospital Universitario Fundación Alcorcón
PhaseNA
StatusSuspended
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment386
Start date1 May 2024
Primary completion20 May 2025
Estimated completion20 May 2025
Sites1 location across Spain

Drugs / interventions tested

Conditions studied

Sponsor

Hospital Universitario Fundación Alcorcón

Who can join

40 and older, any sex, with Meniscus Tear. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this multicenter non-controlled study is to develop a multivariable prediction model of pain/disability improvements in patients with meniscal tears, after a physical therapy treatment based on therapeutic exercise and education.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Therapeutic resistance exercise

Trials testing the same drug.

Other recruiting trials for Meniscus Tear

Currently open trials in the same condition.

Other Hospital Universitario Fundación Alcorcón trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05909865.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing